News + Filings Transactions Holdings
|
Opaleye Management Inc.
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
ACELYRIN, Inc.
| SLRN | Common | 4,158,638 | 4,158,638 | 86,915,534,000 | 86,915,534,000 | 20.79 | |
Hist
| 06/30/2023 |
HARROW HEALTH, INC.
| HROW | COM | 3,775,000 | 431,183 | 71,876,000,000 | 71,835,640,000 | 17.19 | 12.53 |
Hist
| 06/30/2023 |
OCULAR THERAPEUTIX, INC
| OCUL | COM | 5,780,000 | -685,000 | 29,824,800,000 | 29,797,970,000 | 7.13 | 7.46 |
Hist
| 06/30/2023 |
TELA Bio, Inc.
| TELA | Common | 1,580,000 | -456,551 | 16,005,400,000 | 15,988,049,000 | 3.83 | 6.46 |
Hist
| 06/30/2023 |
Crinetics Pharmaceuticals, Inc.
| CRNX | Common | 845,000 | 173,700 | 15,226,900,000 | 15,213,716,000 | 3.64 | 1.56 |
Hist
| 06/30/2023 |
Keros Therapeutics, Inc.
| KROS | Common | 352,650 | 31,350 | 14,169,477,000 | 14,157,390,000 | 3.39 | |
Hist
| 06/30/2023 |
Biohaven Pharmaceutical Holding Co Ltd.
| BHVN | COM | 540,000 | 540,000 | 12,916,800,000 | 12,916,800,000 | 3.09 | |
Hist
| 06/30/2023 |
RHYTHM PHARMACEUTICALS, INC.
| RYTM | Common | 735,000 | -75,000 | 12,120,150,000 | 12,100,305,000 | 2.90 | 1.30 |
Hist
| 06/30/2023 |
IDEAYA Biosciences, Inc.
| IDYA | Common | 415,000 | 413,500 | 9,752,500,000 | 9,752,478,000 | 2.33 | 0.86 |
Hist
| 06/30/2023 |
MorphoSys AG
| MOR | SPONSORED ADS | 1,209,380 | 1,088,365 | 9,034,069,000 | 9,033,460,000 | 2.16 | |
Hist
| 06/30/2023 |
Vaxcyte, Inc.
| PCVX | Common | 177,000 | -13,000 | 8,839,380,000 | 8,834,820,000 | 2.11 | 0.19 |
Hist
| 06/30/2023 |
Eton Pharmaceuticals, Inc.
| ETON | Common | 2,285,000 | -236,000 | 7,974,650,000 | 7,969,356,000 | 1.91 | 8.96 |
Hist
| 06/30/2023 |
GERON CORP
| GERN | COM | 2,350,000 | 2,350,000 | 7,543,500,000 | 7,543,500,000 | 1.80 | 0.46 |
Hist
| 06/30/2023 |
MARINUS PHARMACEUTICALS, INC.
| MRNS | Common | 625,000 | 625,000 | 6,787,500,000 | 6,787,500,000 | 1.62 | 1.24 |
Hist
| 06/30/2023 |
KalVista Pharmaceuticals, Inc.
| KALV | Common | 720,000 | 720,000 | 6,480,000,000 | 6,480,000,000 | 1.55 | 2.10 |
Hist
| 06/30/2023 |
Protara Therapeutics, Inc.
| TARA | COM | 2,692,594 | -15,473 | 6,435,300,000 | 6,427,307,000 | 1.54 | 23.81 |
Hist
| 06/30/2023 |
Edgewise Therapeutics, Inc.
| EWTX | Common | 815,000 | 180,000 | 6,316,250,000 | 6,310,002,000 | 1.51 | 1.29 |
Hist
| 06/30/2023 |
CymaBay Therapeutics, Inc.
| CBAY | Common | 566,700 | 566,700 | 6,205,365,000 | 6,205,365,000 | 1.48 | 0.58 |
Hist
| 06/30/2023 |
UroGen Pharma Ltd.
| URGN | Common | 570,000 | 172,500 | 5,899,500,000 | 5,896,193,000 | 1.41 | 2.43 |
Hist
| 06/30/2023 |
Theravance Biopharma, Inc.
| TBPH | COM | 543,500 | 543,500 | 5,625,225,000 | 5,625,225,000 | 1.35 | 0.94 |
Hist
| 06/30/2023 |
Theseus Pharmaceuticals, Inc.
| THRX | Common | 597,500 | 376,850 | 5,574,675,000 | 5,573,395,000 | 1.33 | 1.37 |
Hist
| 06/30/2023 |
ACADIA PHARMACEUTICALS INC
| ACAD | Common | 217,000 | 217,000 | 5,197,150,000 | 5,197,150,000 | 1.24 | 0.13 |
Hist
| 06/30/2023 |
Intellia Therapeutics, Inc.
| NTLA | Common | 120,000 | 120,000 | 4,893,600,000 | 4,893,600,000 | 1.17 | 0.14 |
Hist
| 06/30/2023 |
Liquidia Technologies Inc
| LQDA | Common | 570,700 | 7,200 | 4,479,995,000 | 4,476,930,000 | 1.07 | |
Hist
| 06/30/2023 |
Larimar Therapeutics, Inc.
| ZFGN | Common | 1,390,000 | -271,784 | 4,350,700,000 | 4,345,382,000 | 1.04 | |
Hist
| 06/30/2023 |
CYTOKINETICS INC
| CYTK | COM NEW | 130,000 | -133,000 | 4,240,600,000 | 4,227,858,000 | 1.01 | 0.14 |
Hist
| 06/30/2023 |
Trevi Therapeutics, Inc.
| TRVI | Common | 1,701,500 | 1,701,500 | 4,066,585,000 | 4,066,585,000 | 0.97 | 2.83 |
Hist
| 06/30/2023 |
Gossamer Bio, Inc.
| GOSS | COM | 3,370,000 | 3,370,000 | 4,044,000,000 | 4,044,000,000 | 0.97 | 3.53 |
Hist
| 06/30/2023 |
4D Molecular Therapeutics, Inc.
| FDMT | Common | 221,700 | -129,000 | 4,006,119,000 | 4,003,299,000 | 0.96 | 0.67 |
Hist
| 06/30/2023 |
Nyxoah SA
| NYXH | Common | 445,000 | 445,000 | 3,564,450,000 | 3,564,450,000 | 0.85 | 1.72 |
Hist
| 06/30/2023 |
EDAP TMS SA
| EDAP | SPONSORED ADR | 380,000 | 308,700 | 3,503,600,000 | 3,503,012,000 | 0.84 | |
Hist
| 06/30/2023 |
Karyopharm Therapeutics Inc.
| KPTI | Common | 1,785,000 | 1,785,000 | 3,195,150,000 | 3,195,150,000 | 0.76 | |
Hist
| 06/30/2023 |
IOVANCE BIOTHERAPEUTICS, INC.
| IOVA | COM | 421,000 | 421,000 | 2,963,840,000 | 2,963,840,000 | 0.71 | 0.19 |
Hist
| 06/30/2023 |
Stereotaxis, Inc.
| STXS | COM NEW | 3,074,995 | 1,518,195 | 2,951,995,000 | 2,949,193,000 | 0.71 | 3.81 |
Hist
| 06/30/2023 |
Astria Therapeutics, Inc.
| ATXS | Common | 305,000 | 171,500 | 2,540,650,000 | 2,539,443,000 | 0.61 | 1.09 |
Hist
| 06/30/2023 |
<< Prev Next >> |
|
|
|
|